AI Article Synopsis
- The study evaluates the cost-effectiveness of a kindergarten-based amblyopia screening program for 3-year-old children in China, comparing it to no screening.
- The analysis showed an incremental cost-effectiveness ratio (ICER) of $17,466 per quality-adjusted life year (QALY), which is below China's willingness-to-pay (WTP) threshold of $38,223/QALY.
- Results indicate a high likelihood (92.56%) that screening is cost-effective, even if delayed to ages 4 or 5, supporting the implementation of such programs in China.
Article Abstract
Objective: Current cost-effectiveness analyses of amblyopia screening are mainly from western countries. It remains unclear whether it is cost-effective to implement a preschool amblyopia screening programme in China. Our study aimed to evaluate the cost-effectiveness of a hypothetical kindergarten-based amblyopia screening versus non-screening among 3-year-old children.
Methods: We developed a decision tree combined with a Markov model to compare the cost and effectiveness of screening versus non-screening for 3-year-old children from a third-party payment perspective. The primary outcomes were quality-adjusted life years (QALYs) and the incremental cost-effectiveness ratio (ICER). Costs were obtained from expert opinions in different regions of China. Transition probabilities and health utilities were mainly based on published literature and open sources. Sensitivity analyses were performed to assess the impact of parameters' uncertainty on results.
Results: Base-case analysis demonstrated that the ICER of screening versus non-screening was $17,466/QALY, well below the WTP threshold ($38,223/QALY) for China. One-way sensitivity analysis showed that the prevalence of amblyopia, the transition probability per year from untreated amblyopia to healthy, and the discount rate were the top three factors. The likelihood of cost-effectiveness of screening compared with non-screening was 92.56%, according to probabilistic sensitivity analysis. Scenario analysis also indicated that ICER was lower than the WTP threshold even if the time horizon was shortened or the screening was delayed to the age of 4 or 5.
Conclusions: Amblyopia screening could be considered a cost-effective strategy compared to non-screening for 3-year-old children in China. Screening for children at the age of 4 or 5 may even yield better results.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10901851 | PMC |
| http://dx.doi.org/10.1016/j.pmedr.2024.102662 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Amblyopia screening: the current state and opportunities for optimization.
Expert Rev Med Devices
January 2025
Division of Ophthalmology, Children's Hospital of Philadelphia.
Introduction: Amblyopia, the leading cause of monocular childhood vision loss, affects millions and is projected to increase. Early detection and treatment are crucial for preventing vision impairment.
Areas Covered: This commentary reviews the current state and opportunities for improvement in amblyopia screening strategy and technology focused primarily within the United States.
Amblyopic binocular imbalance quantified by the dichoptic contrast ordering test and dichoptic letters test.
Sci Rep
January 2025
Department Ophthalmology and Visual Sciences, McGill Vision Research, McGill University, Montreal, QC, Canada.
In amblyopia, abnormal binocular interactions lead to an overwhelming dominance of one eye. One mechanism implied in this imbalance is the suppression between the inputs from the two eyes. This interocular suppression involves two components: an overlay suppression and a surround suppression.
View Article and Find Full Text PDFValidating Rules for Defining No Improvement of Visual Acuity in Childhood Amblyopia.
Invest Ophthalmol Vis Sci
January 2025
Southern California College of Optometry at Marshall B Ketchum University, Fullerton, California, United States.
Article Synopsis
- The study emphasizes the importance of identifying when visual acuity (VA) in amblyopia patients has stabilized to inform treatment choices.
- The researchers simulated various VA measurements to assess the accuracy (false-positive and false-negative rates) of different rules for determining VA stability across multiple visits and treatments.
- Results showed significant variability in false-positive and false-negative rates depending on the measurement rules used, suggesting that clinicians should choose rules based on whether they want to minimize overlooking stabilization or misclassifying improvement.
[Further raising prevention and treatment for amblyopia in China].
Zhonghua Yan Ke Za Zhi
January 2025
Tianjin Eye Hospital, Nankai University Affiliated Eye Hospital, Clinical College of Ophthalmology of Tianjin Medical University, Tianjin Eye Institute, Tianjin Key Laboratory of Ophthalmology and Visual Science, Tianjin300020, China.
Amblyopia is a common eye disease that seriously affects children's eye health. The Chinese Association for Pediatric Ophthalmology and Strabismus has carried out a lot of work for the prevention and treatment of amblyopia, but there are still many problems that need to be paid attention to and solved in the amblyopia screening and clinical diagnosis and treatment. In this article, we discuss three aspects of the amblyopia prevention and treatment, including the timing of prevention and treatment according to visual developmental patterns, the standardized treatment of amblyopia, overdiagnosis and commercialization, and the establishment of an efficient amblyopia screening system, for providing guidance for the standardization of clinical practice and improving the level of amblyopia prevention and treatment in China.
View Article and Find Full Text PDFOrbital Lymphangioma in an Adolescent Male: A Case Report and Review of Literature.
Cureus
November 2024
Radiodiagnosis, MNR Medical College and Hospital, Sangareddy, IND.
Lymphangiomas are localized multi-cystic malformations of the lymphatic and vascular system, primarily affecting the head and neck regions in children. Orbital lymphangiomas are not considered hamartomas because the orbit does not commonly display lymphatic vessels. In this case report, we describe a male patient who was 15 years old and presented to our medical facility with the primary complaints of having a bulging left eye, sudden chemosis of the lower conjunctiva, and pain in the left eye.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!